The 4G/5G polymorphism of PAI-1 promoter gene and the risk of myocardial infarction: A meta-analysis

被引：0
|
作者：
Iacoviello, L [1 ]
Burzotta, F
Di Castelnuovo, A
Zito, F
Marchioli, R
Donati, MB
机构：
[1] Ist Ric Farmacol Mario Negri, Consorzio Mario Negri Sud, Angela Valenti Lab Thrombosis Pharmacol, Dept Vasc Med & Pharm,Un Gen Vasc Risk Fact, I-66030 Santa Maria Imbaro, Italy
[2] Ist Ric Farmacol Mario Negri, Consorzio Mario Negri Sud, Dept Clin Pharmacol & Epidemiol, Lab Clin Epidemiol Cardiovasc Dis, I-66030 Santa Maria Imbaro, Italy
[3] TNO, PG, Gaubius Lab, Leiden, Netherlands
来源：
THROMBOSIS AND HAEMOSTASIS | 1998年 / 80卷 / 06期
关键词：
D O I：
暂无
中图分类号：
R5 [内科学];
学科分类号：
1002 ; 100201 ;
摘要：
引用
收藏
页码：1029 / 1030
页数：2
相关论文
共 50 条
  • [41] Plasminogen activator inhibitor-1 (PAI-1) 4G/5G promoter polymorphisms and risk of venous thromboembolism - a meta-analysis and systematic review
    Zhang, Qiang
    Jin, YunRui
    Li, XueMei
    Peng, XingQiao
    Peng, Na
    Song, JiFang
    Xu, Mingfang
    VASA-EUROPEAN JOURNAL OF VASCULAR MEDICINE, 2020, 49 (02) : 141 - 146
  • [42] Association between PAI-1 4G/5G Polymorphisms and osteonecrosis of femoral head: A Meta-analysis
    Liang, Xiao-Nan
    Xie, Li
    Cheng, Jian-Wen
    Tan, Zhen
    Yao, Jun
    Liu, Qian
    Su, Wei
    Qin, Xue
    Zhao, Jin-Min
    THROMBOSIS RESEARCH, 2013, 132 (02) : 158 - 163
  • [43] Plasminogen activator inhibitor-1 (PAI-1) activity post myocardial infarction: the role of acute phase reactants, insulin-like molecules and promoter (4G/5G) polymorphism in the PAI-1 gene
    Panahloo, A
    Mohammad-Ali, V
    Gray, RP
    Humphries, SE
    Yudkin, JS
    ATHEROSCLEROSIS, 2003, 168 (02) : 297 - 304
  • [44] The 4G/5G sequence polymorphism in the promoter of plasminogen activator inhibitor-1 (PAI-1) gene: Relationship to plasma PAI-1 level in venous thromboembolism
    Stegnar, M
    Uhrin, P
    Peternel, P
    Mavri, A
    Salobir-Pajnic, B
    Stare, J
    Binder, BR
    THROMBOSIS AND HAEMOSTASIS, 1998, 79 (05) : 975 - 979
  • [45] Possessing 4G allele of PAI-1 4G/5G polymorphism has a protective effect against development of myocardial infarction at very young ages
    Rallidis, L.
    Sourides, V.
    Gialeraki, A.
    Merkouri, E.
    Sionis, D.
    Travlou, A.
    Lekakis, J.
    Kremastinos, D.
    EUROPEAN HEART JOURNAL, 2009, 30 : 953 - 953
  • [46] Regular exercise, plasminogen activator inhibitor-1 (PAI-I) activity and the 4G/5G promoter polymorphism in the PAI-1 gene
    Väisänen, SB
    Humphries, SE
    Luong, LA
    Penttilä, I
    Bouchard, C
    Rauramaa, R
    THROMBOSIS AND HAEMOSTASIS, 1999, 82 (03) : 1117 - 1120
  • [47] Bilateral pulmonary embolism in twins with PAI-1 4G/5G gene polymorphism: a case reportZwillinge mit bilateraler Pulmonalembolie und PAI-1 4G/5G Genpolymorphismus: Ein Fallbericht
    Andreas Kronbichler
    Peter Oelzner
    Günter Syrbe
    Eric Lopatta
    Gunter Wolf
    Thomas Neumann
    Wiener klinische Wochenschrift, 2014, 126 : 53 - 55
  • [48] Myocardial infarction in African-Americans is associated with insertion/deletion polymorphism of the T-PA gene but not with the PAI-1 4G/5G polymorphism.
    Hooper, WC
    Dilley, A
    Lally, C
    Evatt, BL
    Cole, D
    Benson, J
    Wenger, NK
    BLOOD, 1997, 90 (10) : 669 - 669
  • [49] Role of the PAI-1 gene 4G/5G polymorphism on PAI-1 level and relations among PAI-1, TNFα and TGFβ levels in obese children
    Ozbek, N.
    Kinik, S. Tulgar
    Atac, B.
    Yuce, M.
    Yazici, A. C.
    Verdi, H.
    HAEMATOLOGICA-THE HEMATOLOGY JOURNAL, 2007, 92 : 124 - 124
  • [50] PAI-1 gene 4G/5G polymorphism and risk of type 2 diabetes in a population-based sample
    Meigs, James B.
    Dupuis, Josee
    Liu, Chunyu
    O'Donnell, Christopher J.
    Fox, Caroline S.
    Kathiresan, Sekar
    Gabriel, Stacey B.
    Larson, Martin G.
    Yang, Qiong
    Herbert, Alan G.
    Wilson, Peter W. F.
    Feng, DaLi
    Tofler, Geoffrey H.
    Cupples, L. Adrienne
    OBESITY, 2006, 14 (05) : 753 - 758
12345